PDX-1 related diabetes: a case series of two families highlighting challenges in MODY diagnosis

Beatriz Tavares da Silva1, Ana Torrão Pinheiro2, Miguel Saraiva2

  • 1Division of Endocrinology, Local Health Unit of Santo António, Centro Hospitalar Universitário de Santo António, Largo Prof. Abel Salazar, 4099-001, Porto, Portugal. beatriztavaresdasilva.md@gmail.com.

Acta Diabetologica
|November 7, 2025
PubMed

Insights

PDX1-MODY, a rare genetic diabetes, shows significant clinical and genetic diversity. Understanding these PDX1 gene variants is crucial for diagnosing early-onset diabetes.

Area of Science:

  • Genetics
  • Endocrinology
  • Molecular Biology

Background:

  • PDX1-MODY is a rare, dominantly inherited monogenic diabetes caused by PDX1 (IPF1) gene variants.
  • It characteristically presents with early-onset, non-ketotic hyperglycemia and variable insulin needs.

Purpose of the Study:

  • To investigate the clinical and genetic heterogeneity of PDX1-MODY.
  • To expand the understanding of the PDX1-MODY mutational and phenotypic spectrum.

Main Methods:

  • Next-generation sequencing (NGS) using a 36-gene panel for monogenic diabetes.
  • Variant classification according to ACMG/AMP 2015 guidelines.

Main Results:

  • Two unrelated families with confirmed PDX1 variants (p.Glu105* and p.Glu164Asp) were identified.
  • Both pedigrees demonstrated preserved C-peptide secretion, absence of autoimmune markers, and progressive beta-cell dysfunction.
  • Variants were classified as "pathogenic" and "likely pathogenic".

Conclusions:

  • These cases highlight the clinical and genetic heterogeneity of PDX1-MODY.
  • The findings underscore the importance of considering monogenic diabetes in antibody-negative, early-onset hyperglycemia cases.

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...